Log in

Kalvista Pharmaceuticals SEC Filings & 10K Form (NASDAQ:KALV)

$13.96
-0.19 (-1.34 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$13.84
Now: $13.96
$14.18
50-Day Range
$13.96
MA: $16.21
$18.56
52-Week Range
$9.86
Now: $13.96
$34.92
Volume43,330 shs
Average Volume78,624 shs
Market Capitalization$248.91 million
P/E RatioN/A
Dividend YieldN/A
Beta2.24

SEC Filings

Kalvista Pharmaceuticals (NASDAQ:KALV) SEC Filings

DateFilerForm TypeView
02/13/2020
11:45 AM
Flynn James E (Filed by)
Kalvista Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
4:18 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:17 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:14 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:32 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:30 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:34 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:32 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
3:30 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
4:26 PM
Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
4:25 PM
Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
4:24 PM
Kalvista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:00 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
4:23 PM
Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:18 PM
Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/09/2019
3:15 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
6:20 AM
Kalvista Pharmaceuticals (Filer)
Form DEF 14A
07/30/2019
6:37 PM
Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
4:53 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
4:52 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
5:38 PM
Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
5:52 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
3:20 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
6:15 AM
Kalvista Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/16/2019
5:50 AM
Kalvista Pharmaceuticals (Filer)
Form NT 10-K
07/01/2019
3:15 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
4:36 PM
Edwards Martin (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:35 PM
Edwards Martin (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2019
4:50 PM
Kalvista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2019
4:44 PM
Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:34 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:29 PM
Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:22 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:17 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
3:42 PM
Kalvista Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
04/24/2019
3:41 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
4:33 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
4:30 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
4:29 PM
Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
4:27 PM
Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2019
4:58 PM
Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
5:30 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
3:35 PM
Kalvista Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
04/10/2019
6:21 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
4:33 PM
Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
2:27 PM
Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13D/A
04/02/2019
5:57 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
4:25 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
4:22 PM
Kalvista Pharmaceuticals (Filer)
Form 424B5
03/28/2019
4:29 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
3:43 PM
Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13D/A
03/20/2019
3:13 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
3:08 PM
Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
7:03 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:52 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
3:44 PM
Kalvista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/14/2019
3:16 PM
Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/06/2019
8:05 AM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
7:30 AM
Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13D/A
02/21/2019
1:35 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
4:41 PM
Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
4:39 PM
Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2019
3:30 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2019
5:53 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
6:48 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
6:44 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4/A
01/18/2019
4:42 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
5:25 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
4:12 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
6:10 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2018
11:16 PM
Kalvista Pharmaceuticals (Filer)
Form EFFECT
12/21/2018
3:19 PM
Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
4:17 PM
Kalvista Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/14/2018
3:16 PM
Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/14/2018
6:53 AM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
5:08 PM
Kalvista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
5:07 PM
Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
5:05 PM
Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
5:03 PM
ALDRICH RICHARD (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
3:00 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
3:00 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
6:35 PM
Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
6:33 PM
Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
6:31 PM
Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
6:29 PM
Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
6:26 PM
Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:11 PM
Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/12/2018
6:16 PM
Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
6:11 PM
Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
3:32 PM
Kalvista Pharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
Form SC 13G
09/10/2018
3:30 PM
Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
09/10/2018
3:27 PM
Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2018
8:59 PM
Kalvista Pharmaceuticals (Filer)
Form 424B5
09/06/2018
3:02 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
4:03 PM
Kalvista Pharmaceuticals (Filer)
Form 424B5
08/15/2018
3:10 PM
Kalvista Pharmaceuticals (Filer)
Form DEF 14A
08/09/2018
3:33 PM
Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
08/01/2018
3:59 PM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2018
3:46 PM
Kalvista Pharmaceuticals (Filer)
Form 424B5
07/31/2018
7:30 AM
Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel